PetVivo Holdings Valuation Multiples

PetVivo Holdings is valued at $24M as of November 2026, a 21.3x revenue multiple. In the last fiscal year, PetVivo Holdings revenue was $1M and PetVivo Holdings EBITDA was ($9M).

PetVivo Holdings Overview

About PetVivo Holdings

PetVivo Holdings Inc is an emerging biomedical device company. It is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of several patents. The company has also begun the commercialization of its product Spryng with OsteoCushion technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions such as osteoarthritis in dogs and horses.


Founded

2009

HQ

United States

Employees

24

Financials (Last FY)

Revenue: $1M
EBITDA: ($9M)

EV

$24M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

PetVivo Holdings Financials

PetVivo Holdings reported last fiscal year revenue of $1M and negative EBITDA of ($9M).

In the same fiscal year, PetVivo Holdings generated $755K in gross profit, ($9M) in EBITDA losses, and had net loss of ($10M).


PetVivo Holdings P&L

In the most recent fiscal year, PetVivo Holdings reported revenue of $1M and EBITDA of ($9M).

PetVivo Holdings is unprofitable as of last fiscal year, with gross margin of 66%, EBITDA margin of (778%), and net margin of (917%).

See analyst estimates for PetVivo Holdings
Last FY202320242025202620272028
Revenue$1M$956K$1M$1M
Gross Profit$755K$824K$963K$815K
Gross Margin66%86%88%72%
EBITDA($9M)($10M)($8M)($9M)
EBITDA Margin(778%)(1075%)(776%)(753%)
EBIT Margin(706%)(1062%)(797%)(708%)
Net Profit($10M)($10M)($9M)($10M)
Net Margin(917%)(1088%)(828%)(874%)
Net Debt$175K---

Financial data powered by Morningstar, Inc.

PetVivo Holdings Stock Performance

PetVivo Holdings has current market cap of $24M, and enterprise value of $24M.

Market Cap Evolution


PetVivo Holdings' stock price is $0.63.

PetVivo Holdings share price decreased by 7.5% in the last 30 days, and by 46.6% in the last year.

PetVivo Holdings has an EPS (earnings per share) of $-0.28.

See more trading valuation data for PetVivo Holdings
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$24M$24M0.0%-7.5%-7.4%-46.6%$-0.28

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

PetVivo Holdings Valuation Multiples

PetVivo Holdings trades at 21.3x EV/Revenue multiple, and (2.7x) EV/EBITDA.

See NTM and 2027E valuation multiples for PetVivo Holdings

PetVivo Holdings Financial Valuation Multiples

As of November 8, 2026, PetVivo Holdings has market cap of $24M and EV of $24M.

PetVivo Holdings has a P/E ratio of (2.3x).

Last FY202320242025202620272028
EV/Revenue21.3x25.4x22.3x21.3x
EV/EBITDA(2.7x)(2.4x)(2.9x)(2.8x)
EV/EBIT(3.0x)(2.4x)(2.8x)(3.0x)
EV/Gross Profit32.2x29.5x25.2x29.8x
P/E(2.3x)(2.3x)(2.6x)(2.4x)
EV/FCF(4.0x)(3.2x)(3.8x)(4.0x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified PetVivo Holdings Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

PetVivo Holdings Margins & Growth Rates

In the most recent fiscal year, PetVivo Holdings reported gross margin of 66%, EBITDA margin of (778%), and net margin of (917%).

See estimated margins and future growth rates for PetVivo Holdings

PetVivo Holdings Margins

Last FY202420252026202720282029
Gross Margin66%88%72%66%
EBITDA Margin(778%)(776%)(753%)(778%)
EBIT Margin(706%)(797%)(708%)(706%)
Net Margin(917%)(828%)(874%)(917%)
FCF Margin(536%)(581%)(532%)(536%)

PetVivo Holdings Growth Rates

23/2424/2525/2626/2727/2828/29
Revenue Growth14%4%0%
Gross Profit Growth17%(15%)(7%)
EBITDA Growth(18%)1%3%
EBIT Growth(14%)(7%)0%
Net Profit Growth(13%)10%5%
FCF Growth(17%)(5%)1%

Data powered by FactSet, Inc. and Morningstar, Inc.

PetVivo Holdings Operational KPIs

PetVivo Holdings' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.4M for the same period.

PetVivo Holdings' Rule of 40 is (777%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

PetVivo Holdings' Rule of X is (777%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for PetVivo Holdings
Last FY202320242025202620272028
Rule of 40(777%)---
Bessemer Rule of X(777%)---
Revenue per Employee$0.0M---
Opex per Employee$0.4M---
S&M Expenses to Revenue269%356%260%260%
G&A Expenses to Revenue380%657%485%391%
R&D Expenses to Revenue124%136%141%128%
Opex to Revenue860%1148%885%845%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

PetVivo Holdings Competitors

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E

This data is available for Pro users. Sign up to see all PetVivo Holdings competitors and their valuation data.

Start Free Trial

Acquisitions by PetVivo Holdings

PetVivo Holdings has acquired 2 companies to date.

Last acquisition by PetVivo Holdings was on June 23rd 2026. PetVivo Holdings acquired PiezoBioMembrane for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by PetVivo Holdings

PiezoBioMembrane
Gel-Del Technologies
Description
PiezoBioMembrane is a materials developer. It produces biodegradable substances that exhibit piezoelectric characteristics for applications inside medical implants.
Gel-Del Technologies develops protein-based thermoplastic biomaterials for biomedical devices including dermal fillers, vascular grafts, and drug delivery systems. Its CosmetaLife particles completed an FDA-approved trial outperforming Restylane in wrinkle reduction over 12 months, with applications tested in animal models for orthopedics and cardiology.
HQ CountryUnited StatesUnited States
HQ City
Hartford, CT
Minnesota City, MN
Deal Date23 Jun 20262 Jun 2014
Valuationundisclosed$40M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all PetVivo Holdings acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About PetVivo Holdings

When was PetVivo Holdings founded?PetVivo Holdings was founded in 2009.
Where is PetVivo Holdings headquartered?PetVivo Holdings is headquartered in United States.
How many employees does PetVivo Holdings have?As of today, PetVivo Holdings has over 24 employees.
Is PetVivo Holdings publicly listed?Yes, PetVivo Holdings is a public company listed on OTCM.
What is the stock symbol of PetVivo Holdings?PetVivo Holdings trades under PETV ticker.
When did PetVivo Holdings go public?PetVivo Holdings went public in 2012.
Who are competitors of PetVivo Holdings?PetVivo Holdings main competitors include
What is the current market cap of PetVivo Holdings?PetVivo Holdings' current market cap is $24M.
What is the current revenue of PetVivo Holdings?PetVivo Holdings' last fiscal year revenue is $1M.
What is the current EV/Revenue multiple of PetVivo Holdings?Current revenue multiple of PetVivo Holdings is 21.3x.
Is PetVivo Holdings profitable?No, PetVivo Holdings is not profitable.
How many companies PetVivo Holdings has acquired to date?As of November 2026, PetVivo Holdings has acquired 2 companies.
In how many companies PetVivo Holdings has invested to date?PetVivo Holdings hasn't invested in any companies yet (or none have been disclosed publicly).

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial